{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-23-015278","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2023-11-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.032390+00:00","generated_at":"2026-06-08T01:16:12.086596+00:00","sec_items":["7.01","3.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Alzamend Neuro regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq notice on Nov 15, 2023 confirming compliance with $1.00 minimum bid price rule.","Bid price closed at or above $1.00 for 10 consecutive trading days through Nov 13, 2023.","Company had been at risk of delisting since January 2023; hearing extended deadline to Nov 15.","Separate MVLS deficiency remains; Alzamend must regain compliance with $35M market value rule by March 25, 2024.","Press release issued November 16, 2023 announcing the compliance notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-23-015278","json":"https://secwatch.observer/filing/0001214659-23-015278.json","markdown":"https://secwatch.observer/filing/0001214659-23-015278.md","text":"https://secwatch.observer/filing/0001214659-23-015278.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465923015278/0001214659-23-015278-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465923015278/z11152318k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T01:16:12.086596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b0391f0f9db16aeed659d500706c8b0007de10f6","claim":"Alzamend Neuro, Inc. received a nasdaq deficiency notice notice regarding minimum bid price.","evidence_excerpt":"November 15, 2023. On November 15, 2023, the Company received notice from Nasdaq that the Company has regained compliance with the Minimum Bid Price Requirement and stated that the matter is now closed. On November 16, 2023, the Company issued a press release to announce that the Company has regained compliance with the Minimum Bid Price Requirement. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein. In accordance with General Instruction B.2 of Form 8-K, the information under this item shall not be deemed filed for purposes of Section 18","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1677077/000121465923015278/0001214659-23-015278-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}